HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Sandra Moreno-Mazza Selected Research

JNJ 28871063

2/2008Cellular and in vivo activity of JNJ-28871063, a nonquinazoline pan-ErbB kinase inhibitor that crosses the blood-brain barrier and displays efficacy against intracranial tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Sandra Moreno-Mazza Research Topics

Disease

1Neoplasms (Cancer)
02/2008

Drug/Important Bio-Agent (IBA)

1Phosphotransferases (Kinase)IBA
02/2008
1JNJ 28871063IBA
02/2008
1Tyrosine (L-Tyrosine)FDA Link
02/2008

Therapy/Procedure

1Heterologous Transplantation (Xenotransplantation)
02/2008